- Jobleads-US (New York, NY)
- …2020, further strengthened Menarini's oncology portfolio, adding both commercial and clinical - stage assets. Tagraxofusp is a novel, first in class targeted ... Radius Health to complete the development of Elacestrant, an oral SERD in late - stage Phase 3 development for hormone receptor-positive advanced breast cancer.… more
- Pfizer (New York, NY)
- …the development strategy for programs within the Late - Stage Oncology portfolio. **KEY RESPONSIBILITIES** + Clinical development expert for assigned ... studies maintaining current scientific and clinical knowledge in the specific therapeutic and disease area(s)... Research experience in the phase 3/pivotal space in Oncology , ideally on the side of the sponsor and… more
- Regeneron Pharmaceuticals (Tarrytown, NY)
- …and execution of clinical research and development studies for early and/or late stage assets; Assists with development of the Expanded Synopsis and may ... may contribute to candidate development projects through early and/or late phase development. The Senior Manager reports to the... studies and programs. As a Senior Manager in Oncology Clinical Sciences, **a typical day may… more
- Bristol Myers Squibb (Madison, NJ)
- …through proof of concept trials and will assure a seamless transition into late stage development (Phase II-III trials.) **Governance Participation and Signature ... and franchise aspects for potential in-licensing opportunities that shape the oncology clinical development strategy **Key Competency Requirements:** + Proven… more
- Regeneron Pharmaceuticals (Tarrytown, NY)
- …implementation of clinical biomarker strategies across key programs in early and late stage drug development. Further, this role is responsible for providing ... in pharmaceutical or biotech industry, including a minimum of **5 years in oncology clinical drug development is required** . Does this sound like you? Apply now… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …strategic decision-making. + Build and refine financial models, forecast scenarios, and evaluate clinical and commercial potential of late - stage assets. + ... MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and… more
- Sumitomo Pharma (New York, NY)
- …products in the US, Canada, and Europe, and a diverse pipeline of early- to late - stage assets, we aim to accelerate discovery, research, and development to bring ... CNS. With several marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate discovery, research, and… more
- Sumitomo Pharma (Brooklyn, NY)
- …CNS. With several marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate discovery, research, and ... Pharma America, Inc.), focused on addressing patient needs in oncology , urology, women's health, rare diseases, cell & gene...marketed products and a diverse pipeline of early- to late - stage investigational assets, we aim to accelerate… more
- Insight Global (New York, NY)
- …analyses, and preparing reports to guide asset development from pre-launch through late - stage phases. This includes planning and executing HEOR and real-world ... Evidence (HV&E) Global Access and Value team focused on Thoracic & Precision Medicine Oncology at Pfizer Headquarters in New York City. Reporting to a member of the… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more
- Mitsubishi Chemical Group (New York, NY)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more
- Sanofi Group (Morristown, NJ)
- …of relevant Regulatory Affairs experience (regional and global), in early and late stage , development of multiple modalities; experience within regulatory CMC ... to ensure the delivery of business objectives. This role would support our Oncology therapeutic area. We are an innovative global healthcare company with one… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more
- Mitsubishi Chemical Group (Jersey City, NJ)
- …MTPA's commitment to patients and their communities continues with a robust late - stage pipeline of investigational treatments for difficult-to-treat diseases and ... Parkinson's (PD), Spinal Cord Injury (SCI), and in high unmet areas in Immunology and Oncology . MTPA is rapidly expanding its operations across all functional areas.… more
